SecBot SecBot

CVSI

CV Sciences, Inc.
OTC· Pharmaceutical Preparations· Inc. DE· CIK 0001510964 Biotech & Drug Discovery
$0.010000 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $0.010000
Next earnings
Nov 11
in 15 days
1 year
−75.0%
from $0.0400 · Oct 27
30 days
0.0%
from $0.010000
52-week range
$0.010000–0.0900
−89% from high · low Sep 16
Avg volume 20D
308.8K
Oct 20 spike 2.36M
Short interest
🔒 Subscribers only
Insider net
+$114.8K
1 buyer · 0 sellers · 12 mo
Filing reports
2
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·Next Earnings date, Nov 11, 2026
Strongest🔒 Fresh report (last 24h), subscribers only
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $114.8K at an average $0.0200. No open-market sales. Price is 50% below their cost.

  • TrendDOWNTREND

    32% below its 50-day average. New closing low $0.010000 on Oct 26.

The Street

last action Dec 2021
Recent actions
DateFirmActionRating
Dec 10, 2021Cantor Fitzgerald
MAINTAIN
MAINTAINNeutral
Mar 19, 2021Roth Capital
MAINTAIN
MAINTAINNeutral
Mar 19, 2021Piper Sandler
DOWNGRADE
DOWNGRADENeutral
Jan 29, 2021Cantor Fitzgerald
DOWNGRADE
DOWNGRADENeutral
Jun 12, 2020Cowen & Co.
INITIATE
INITIATEMarket Perform
Apr 7, 2020Cantor Fitzgerald
MAINTAIN
MAINTAINOverweight
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 11, 2026
Earnings date
CVSI Q3 2026 Earnings Scheduled — 2026-11-11
Recent
Aug 11, 2026
Earnings date
CVSI Q2 2026 Earnings Scheduled — 2026-08-11
May 8, 2026
Earnings date
CVSI Q1 2026 Earnings Scheduled — 2026-05-08
Mar 26, 2026
Earnings date
CVSI Q4 2025 Earnings Scheduled — 2026-03-26

Insider ledger

Form 4
$114.8K
bought · 1 insider
$0
sold · 0 insiders
−50.0%
vs their $0.0200 cost
DateInsiderTypeValue
Aug 7, 2026
CHEEVER CHARLIE E III
10%+ Owner
BUY$1.9K
Aug 4, 2026
CHEEVER CHARLIE E III
10%+ Owner
BUY$2.2K
Jul 31, 2026
CHEEVER CHARLIE E III
10%+ Owner
BUY$34.6K
Jul 29, 2026
CHEEVER CHARLIE E III
10%+ Owner
BUY$1.2K
Jul 28, 2026
CHEEVER CHARLIE E III
10%+ Owner
BUY$36.6K
Jul 24, 2026
CHEEVER CHARLIE E III
10%+ Owner
BUY$9.4K
Jul 22, 2026
CHEEVER CHARLIE E III
10%+ Owner
BUY$5.5K
Jul 21, 2026
CHEEVER CHARLIE E III
10%+ Owner
BUY$6.7K

Earnings setup

Estimates
Nov 11
reports in 15 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 26, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Aug 11, 2026 Earnings calendar
CVSI Q2 2026 Earnings Scheduled — 2026-08-11
Aug 7, 2026 Insider
CHEEVER CHARLIE E III bought 94,854 shares
10%+ Owner @ $0.0200 ($1.9K)
Aug 4, 2026 Insider
CHEEVER CHARLIE E III bought 108,000 shares
10%+ Owner @ $0.0200 ($2.2K)
Jul 31, 2026 Insider
CHEEVER CHARLIE E III bought 1,730,000 shares
10%+ Owner @ $0.0200 ($34.6K)
Apr 10, 2026 SEC
CV Sciences issued a $99,614.04 senior secured convertible note to an institutional investor on April 6, 2026, and…
8-K — Impact 6/10

SecBot reports

2 filings · 0 bullish · 1 bearish · 1 neutral
All CVSI filing & press-release reports (2)